Early cardiac involvement in senile systemic amyloidosis: a case report

References

• Westermark P, Benson M D, Buxbaum J N, Cohen A S, Frangione B, Ikeda S, Masters C L, Merlini G, Saraiva M, Sipe J D. Amyloid: toward terminology clarification. Report from the nomenclature committee of the international society of amyloidosis. Amyloid. The Journal of Protein Folding Disorders 2005; 12: 1–4
   PubMed Web of Science ®Google Scholar
• Kyle R A, Gertz M A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45–59
   PubMed Web of Science ®Google Scholar
• Cornwell G G, 3rd, Murdoch W L, Kyle R A, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983; 75: 618–623
   PubMed Web of Science ®Google Scholar
• Westermark P, Bergström J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid. The Journal of Protein Folding Disorders 2003; 10(Suppl. 1)48–54
   PubMed Web of Science ®Google Scholar
• Wizenberg T A, Muz J, Sohn Y H, Samlowski W, Weissler A M. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 1982; 103: 468–473
   PubMed Web of Science ®Google Scholar
• Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, Takahashi M, Ishihara T. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain contrast region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001; 51: 264–270
   PubMed Web of Science ®Google Scholar
• Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y-F, Masuda Y, Ikeda S. Usefulness of MALD-TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid. The Journal of Protein Folding Disorders 1999; 6: 282–288
   PubMed Web of Science ®Google Scholar
• Ikeda S. Cardiac amyloidosis: heterogenous pathogenic backgrounds. Intern Med 2004; 43: 1107–1114
   PubMed Web of Science ®Google Scholar
• Dubrey S W, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk R H. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med 1998; 91: 141–157
   Google Scholar
• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan. Clinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
   PubMed Web of Science ®Google Scholar
• Connors L H, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. The Journal of Protein Folding Disorders 2003; 10: 160–184
   PubMed Web of Science ®Google Scholar
• Takahashi K, Sakashita N, Ando Y, Suga M, Ando M. Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 autopsy cases of ordinary type. Pathol Int 1997; 47: 353–358
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell G G, 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990; 87: 2843–2845
   PubMed Web of Science ®Google Scholar
• Kyle R A, Spittell P C, Gertz M A, Li C-Y, Edwards W D, Olson L J, Thibodeau S N. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996; 171: 395–400
   Web of Science ®Google Scholar
• Takei Y, Hattori T, Gono T, Tokuda T, Saitoh S, Hoshii Y, Ikeda S. Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome. Amyloid. The Journal of Protein Folding Disorders 2002; 9: 252–255
   PubMed Web of Science ®Google Scholar
• Takei Y, Hattori T, Tokuda T, Matsuda M, Saitoh T, Hoshii Y, Ikeda S. Senile systemic amyloidosis starting as bilateral carpal and left ulnar tunnel syndrome. Intern Med 2003; 42: 1050–1051
   PubMed Web of Science ®Google Scholar
• Johanson B, Westermark P. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991; 32: 83–92
   PubMed Web of Science ®Google Scholar
• Olson L J, Gertz M A, Edwards W D, Li C-Y, Pellikka P A, Holmes D R, Tajik A J, Kyle R A. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 1987; 317: 738–742
   PubMed Web of Science ®Google Scholar
• Gorevic P D, Prelli F C, Wright J, Pras M, Frangione B. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989; 83: 836–843
   PubMed Web of Science ®Google Scholar
• Jacobson D R, Pastore R D, Yaghoubian R, Kane I, Gallo G, Buck F S, Buxbaum J N. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336: 466–473
   PubMed Web of Science ®Google Scholar
• Belinda Ng, Connors L H, Davidoff R, Skinner M, Falk R H. Senile systemic amyloidosis presenting with heart failure. Arch Intern Med 2005; 265: 1425–1429
   Google Scholar
• Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid. The Journal of Protein Folding Disorders 2003; 10: 229–239
   PubMed Web of Science ®Google Scholar
• Ogiwara F, Koyama J, Ikeda S, Kinoshita O, Falk R H. Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol 2005; 95: 538–540
   PubMed Web of Science ®Google Scholar
• Skinner M, Sanchorawala V, Seldin D C, Dember L M, Falk R H, Berk J L, Anderson J J, O'Hara C, Finn K T, Libbey C A, Wiesman J, Quillen K, Swan N, Wright D G. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004; 140: 85–93
   PubMed Web of Science ®Google Scholar
• Gono T, Matsuda M, Shimojima Y, Ishii W, Koyama J, Sakashita K, Kioke K, Hoshii Y, Ikeda S. VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection. Amyloid. The Journal of Protein Folding Disorders 2004; 11: 245–256
   PubMed Web of Science ®Google Scholar
• Fuchs U, Zittermann A, Suhr O, Holmgren G, Tenderich G, Minami K, Koerfer R. Heart transplantation in a 68-year-old patient with senile systemic amyloidosis. Am J Transplant 2005; 5: 1159–1162
   PubMed Web of Science ®Google Scholar
• Rice G PA, Ebers G C, Newland F, Wysocki G P. Recurrent cerebral embolism in cardiac amyloidosis. Neurology 1981; 31: 904–906
   PubMed Web of Science ®Google Scholar
• Owa M, Takei Y, Hashikura Y, Kawasaki S, Koyama M, Ikeda S. Recurrent cerebral embolism in a familial amyloid polyneuropathy patient who received partial liver transplantation from a living donor. Intern Med 2001; 40: 259–264
   PubMed Web of Science ®Google Scholar
• Miller S R, Sekijima S, Kelly J W. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab Invest 2004; 84: 545–552
   PubMed Web of Science ®Google Scholar
• Tojo K, Sekijima Y, Kelly J W, Ikeda S. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis. Neurosci Res 2006; 56: 441–449
   PubMed Web of Science ®Google Scholar